Insiders Have Traded HCA Healthcare Inc. (HCA) Stock In What Way?

The stock of HCA Healthcare Inc. (NYSE:HCA) decreased by decreased by -$6.89 on Friday to finish at $253.11, down -2.65 percent. The last five days have seen an average of 1,524,860 shares of common stock traded. 33 times new highs were reached in the current year, with a gain of $88.65. The average number of shares traded over the last 20 days was 1,406,810, while the average volume over the last 50 days totaled 1,368,172.

HCA stock dropped -0.95% since last month. On 10/06/21, the company’s shares reached a one-month low of $236.03. The stock touched a high of $263.92 on 09/17/21, after rallying from a low of $121.91 in 52 weeks. The price of HCA stock has risen by 53.90% or $88.65 this year, reaching a new high 33 times. Still, the stock price is down -4.10% from the 52-week high.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


Insider Transactions

There have been 81 days since HCA Healthcare Inc. (HCA) last reported insider trading activity on Aug 05. On Aug 05, SVP and Chief Nursing Officer Englebright Jane D. sold 4,018 shares at $250.12 each. This transaction resulted in the insider making $1,004,997. On Aug 03, Cuffe Michael S. sold 2,500 shares at a price of US$251.91. After the transaction, the insider now owns 17,914 shares. Group President Hall Charles J had earlier sold 6,000 shares on Aug 03 for $252.94 a share. The transaction was completed for $1,517,640.

Valuation Metrics

HCA Healthcare Inc. (HCA) has a trailing price-to-earnings (P/E) ratio of 17.36. This level actually compares favorably with the industry at large, as the PE for the Medical Care Facilities industry stands at about 21.54. Further, its PE also compares favorably with the Healthcare sector’s trailing 12 months PE ratio, which comes in at 33.43 right now. The PE ratio of HCA Healthcare Inc. has varied between 17.95 and 6.766 in the last five years. Beta for the stock is 1.64. There are also a few other valuation ratios worth considering, including the trailing price-to-sales (P/S) ratio of 1.49, and the price-to-cash flow ratio of 11.83.

HCA Healthcare Inc.’s dividend is $1.92 per share per year. With a dividend yield of 0.76%, HCA has a payout ratio of 6.70%. Company paid $0.48 per share in dividends, remained unchanged from $0.48 last year. A $0.2122 dividend increase was reported on Tuesday February 2 2021, making it the 1 consecutive year the dividend has increased.

For the three months ended June 29, HCA Healthcare Inc.’s quick ratio was 1.20, while its current ratio was 1.40, indicating its ability to pay off its debt. As far as profitability goes, gross margin for the trailing twelve months is 83.80% percent. HCA Healthcare Inc.’s EBITDA margin for the year ended June 29 was 19.37%, whereas its operating margin stood at 14.40% for the same period. Based on annual data, it had gross profit of $43.16 billion and revenue of $51.53 billion.

Investors will also look at the performance of the company’s management in order to determine the potential profitability of their investment. HCA’s return on assets (ROA) during the last 12 months has been 9.50%. There was a 18.80% return on investment (ROI) in the past year.

Earnings Surprise

According to HCA Healthcare Inc.’s quarterly financial report for the quarter that ended June 29. A higher net income was reported in the quarter under review than the previous quarter. Net income for the quarter came in at $14.44 billion, while revenues rose by 23.33% to $13.98 billion. It was predicted that HCA Healthcare Inc.’s quarterly earnings would be $4.37, but it ended up being $3.16, beating the consensus by 38.30%. EBITDA was $3.23 billion for the quarter. At the end of HCA Healthcare Inc.’s most recent quarter ended June 29, its liabilities totaled 46.37 billion, while its total debt was $34.37 billion. Equity owned by shareholders amounts to $320.14 million.

Technical Picture

Here’s a quick look at HCA Healthcare Inc.’s (HCA) price momentum from a technical perspective. As of 22 October, the RSI 9-day stood at 58.43%, suggesting the stock is Neutral, with a 24.57% historical volatility rate.

The stochastic %K and %D were 85.04% and 80.67% respectively, while the average true range (ATR) was 6.81. Based on the 14-day stochastic reading of 70.72%, the RSI (14) reading is 55.80%. On the 9-day MACD Oscillator, the stock is at 7.24, and the 14-day reading is at 9.69.

Analyst Ratings

In its analyst report released on September 27, 2021, SVB Leerink began covering HCA Healthcare Inc. (NYSE: HCA). The stock was rated as an Outperform by the brokerage firm. Analysts have assigned HCA Healthcare Inc. (HCA) an Overweight rating. HCA is a stock that is recommended for selling by 0 brokerage firms, while 8 companies recommend holding. The stock is underweighted by 0 analysts. Among the analysts who rate the stock, 1 rate it overweight and 17 others recommend it as a buy.

What is HCA’s price target for the next 12 months?

The current consensus forecast for the stock is between $250.00 and $320.00, with a median target price of $281.50. In analyzing these forecasts, the average price target given by analysts for HCA Healthcare Inc. (HCA) is $282.14.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

spot_img

Hot Topics

Related Videos

Related Videos

Related Articles

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

592

100% free. stop anytime no spam